High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects.


Journal

Nutrition, metabolism, and cardiovascular diseases : NMCD
ISSN: 1590-3729
Titre abrégé: Nutr Metab Cardiovasc Dis
Pays: Netherlands
ID NLM: 9111474

Informations de publication

Date de publication:
29 11 2021
Historique:
received: 17 03 2021
revised: 08 07 2021
accepted: 04 08 2021
pubmed: 10 10 2021
medline: 16 2 2022
entrez: 9 10 2021
Statut: ppublish

Résumé

High glomerular filtration rate (HGFR) is associated with cardiovascular damage in the setting of various conditions such as obesity and diabetes. Prediabetes was also associated with increased GFR, however, the association between prediabetes, HGFR and cardiovascular damage has not been investigated. In this study, we investigated the association between HGFR and early markers of cardiovascular disease in subjects with prediabetes. Augmentation pressure (Aug), augmentation index (AIx), subendocardial viability ratio (SEVR), pulse wave velocity (PWV), intima-media thickness (IMT) and estimated GFR (eGFR) were evaluated in 230 subjects with prediabetes. The eGFR was assessed using the Chronic Kidney Disease Epidemiology Collaboration formula. HGFR was defined as an eGFR above the 75th percentile. Prediabetic subjects were divided into two groups according to presence/absence of HGFR: 61 subjects with HGFR and 169 subjects without HGFR. Subjects with HGFR showed higher Aug, AIx and lower SEVR compared with prediabetic subjects with lower eGFR (14.1 ± 7.2 vs 10.8 ± 6.2, 32.9 ± 12.7 vs 27.6 ± 11.7, 153.5 ± 27.8 vs 162 ± 30.2, p < 0.05). No differences were found in PWV and IMT values between the two groups. Then, we performed multiple regression analysis to test the relationship between Aug, SEVR and several cardiovascular risk factors. In multiple regression analysis Aug was associated with age, systolic blood pressure (BP), HOMA-IR and eGFR; the major determinants of SEVR were systolic BP, HOMA-IR and eGFR. Subjects with prediabetes and HGFR exhibited an increased Aug, AIx and a reduced SEVR. These alterations are associated with eGFR, insulin resistance and systolic BP.

Sections du résumé

BACKGROUND AND AIMS
High glomerular filtration rate (HGFR) is associated with cardiovascular damage in the setting of various conditions such as obesity and diabetes. Prediabetes was also associated with increased GFR, however, the association between prediabetes, HGFR and cardiovascular damage has not been investigated. In this study, we investigated the association between HGFR and early markers of cardiovascular disease in subjects with prediabetes.
METHODS AND RESULTS
Augmentation pressure (Aug), augmentation index (AIx), subendocardial viability ratio (SEVR), pulse wave velocity (PWV), intima-media thickness (IMT) and estimated GFR (eGFR) were evaluated in 230 subjects with prediabetes. The eGFR was assessed using the Chronic Kidney Disease Epidemiology Collaboration formula. HGFR was defined as an eGFR above the 75th percentile. Prediabetic subjects were divided into two groups according to presence/absence of HGFR: 61 subjects with HGFR and 169 subjects without HGFR. Subjects with HGFR showed higher Aug, AIx and lower SEVR compared with prediabetic subjects with lower eGFR (14.1 ± 7.2 vs 10.8 ± 6.2, 32.9 ± 12.7 vs 27.6 ± 11.7, 153.5 ± 27.8 vs 162 ± 30.2, p < 0.05). No differences were found in PWV and IMT values between the two groups. Then, we performed multiple regression analysis to test the relationship between Aug, SEVR and several cardiovascular risk factors. In multiple regression analysis Aug was associated with age, systolic blood pressure (BP), HOMA-IR and eGFR; the major determinants of SEVR were systolic BP, HOMA-IR and eGFR.
CONCLUSION
Subjects with prediabetes and HGFR exhibited an increased Aug, AIx and a reduced SEVR. These alterations are associated with eGFR, insulin resistance and systolic BP.

Identifiants

pubmed: 34625357
pii: S0939-4753(21)00399-9
doi: 10.1016/j.numecd.2021.08.030
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3393-3400

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no competing interests.

Auteurs

Antonino Di Pino (A)

Department of Clinical and Experimental Medicine, University of Catania, Torre Biologica F. Latteri, S. Sofia Street 89, 9512, Catania, Italy.

Roberto Scicali (R)

Department of Clinical and Experimental Medicine, University of Catania, Torre Biologica F. Latteri, S. Sofia Street 89, 9512, Catania, Italy.

Simona Marchisello (S)

Department of Clinical and Experimental Medicine, University of Catania, Torre Biologica F. Latteri, S. Sofia Street 89, 9512, Catania, Italy.

Luca Zanoli (L)

Department of Clinical and Experimental Medicine, University of Catania, Torre Biologica F. Latteri, S. Sofia Street 89, 9512, Catania, Italy.

Viviana Ferrara (V)

Department of Clinical and Experimental Medicine, University of Catania, Torre Biologica F. Latteri, S. Sofia Street 89, 9512, Catania, Italy.

Francesca Urbano (F)

Department of Clinical and Experimental Medicine, University of Catania, Torre Biologica F. Latteri, S. Sofia Street 89, 9512, Catania, Italy.

Agnese Filippello (A)

Department of Clinical and Experimental Medicine, University of Catania, Torre Biologica F. Latteri, S. Sofia Street 89, 9512, Catania, Italy.

Stefania Di Mauro (S)

Department of Clinical and Experimental Medicine, University of Catania, Torre Biologica F. Latteri, S. Sofia Street 89, 9512, Catania, Italy.

Alessandra Scamporrino (A)

Department of Clinical and Experimental Medicine, University of Catania, Torre Biologica F. Latteri, S. Sofia Street 89, 9512, Catania, Italy.

Salvatore Piro (S)

Department of Clinical and Experimental Medicine, University of Catania, Torre Biologica F. Latteri, S. Sofia Street 89, 9512, Catania, Italy.

Pietro Castellino (P)

Department of Clinical and Experimental Medicine, University of Catania, Torre Biologica F. Latteri, S. Sofia Street 89, 9512, Catania, Italy.

Francesco Purrello (F)

Department of Clinical and Experimental Medicine, University of Catania, Torre Biologica F. Latteri, S. Sofia Street 89, 9512, Catania, Italy. Electronic address: fpurrell@unict.it.

Agata M Rabuazzo (AM)

Department of Clinical and Experimental Medicine, University of Catania, Torre Biologica F. Latteri, S. Sofia Street 89, 9512, Catania, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH